Skip to content
Loading...

EASL Statement on Resmetirom FDA approval

After over 20 years of dedicated research and drug development, the FDA has granted approval for the first anti-MASH drug. This marks a pivotal moment for patients battling MASH, whose quality of life and long-term prognosis have been greatly affected…

Read more

Tribute to Sir Roy Calne (1930-2024)

It is with deep sorrow that EASL announces the passing of Sir Roy Calne, a pioneer in the field of transplantation. Sir Calne, a distinguished professor of surgery at Cambridge University, passed away at the age of 93. His remarkable…

Read more

Join the EASL Governance!

Are you ready to propel your career to new heights?    EASL is now looking to fill the following positions:   Three Scientific Committee Members  Four Educational Committee Members  Two Policy, Public Health, and Advocacy Committee Members  Three Young Investigator Task Force members  One Nurses…

Read more
Back To Top